SUMMARY HIV‐1 and HIV‐2 share many similarities including their basic gene
arrangement, modes of transmission, intracellular replication pathways and clinical …

One to two million people worldwide are infected with the human immunodeficiency virus
type 2 (HIV-2), with highest prevalences in West African countries, but also present in …

Single genome sequencing of early HIV-1 genomes provides a sensitive, dynamic
assessment of virus evolution and insight into the earliest anti-viral immune responses in …

Although antibodies to the human immunodeficiency virus type 1 (HIV-1) envelope
glycoprotein have been studied extensively for their ability to block viral infectivity, little data …

The development of a preventative HIV-1 vaccine remains a global public health priority.
This will likely require the elicitation of broadly neutralizing antibodies (bNAbs) able to block …

The simian immunodeficiency virus (SIV) challenge model of lentiviral infection is often used
as a model to human immunodeficiency virus type 1 (HIV-1) for studying vaccine mediated …

Two HIV virus types exist: HIV-1 is pandemic and aggressive, whereas HIV-2 is confined
mainly to West Africa and less pathogenic. Despite the fact that it has been almost 40 years …

Abstract HIV-1 and HIV-2 are the causal agents of AIDS. While similar in many ways, a
significant amount of data suggests that HIV-2 is less virulent than HIV-1. In fact, HIV-2 …

Antibodies specific for diverse epitopes of the simian immunodeficiency virus envelope
glycoprotein (SIV Env) have been isolated from rhesus macaques to provide physiologically …

Background In-depth analysis of the HIV pandemic at its epicenter in the Congo basin has
been hampered by 40 years of political unrest and lack of functional public health …